Net Sales at Rs 440.29 crore in December 2024 up 43.98% from Rs. 305.79 crore in December 2023. Quarterly Net Profit at Rs.

The use of digital twins with industrial, manufacturing and architectural use cases is well known, and in the manifold ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

In this video, Jennifer A. Woyach, MD, discusses results from the AMPLIFY trial, presented at ASH Annual Meeting and Exhibition.The trial evaluated fixed-duration acalabrutinib (Calquence, AstraZeneca ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

AstraZeneca’s Enhertu (trastuzumab deruxtecan) emerged as the highest-selling new drug in India in 2024, generating Rs 58 ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Uganda’s commitment to combating ;non-communicable diseases (NCDs) has earned international recognition at the NCDs Forum in Kigali, Rwanda.Leaders in global health, including ;NCD Alliance chief, ...

Global equity funds attracted significant inflows in the week ending February 12, after a Bank of England rate cut drove a ...